Aspira Women's Health Inc. operates as a biotech company. The Company develops and discovers testing and treatments for gynecologic issues. Aspira Women's Health serves customers in the State of Texas.
Company profile
Ticker
AWH
Exchange
Website
CEO
Valerie Palmieri
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
CIPHERGEN BIOSYSTEMS INC, VERMILLION, INC.
SEC CIK
Corporate docs
Subsidiaries
IllumeSys Pacific, Inc........................................................ • Ciphergen Technologies, Inc.............................................. • ASPiRA Labs, Inc................................................................ • ASPiRA IVD, Inc................................................................ ...
IRS number
330595156
AWH stock data
Analyst ratings and price targets
Latest filings (excl ownership)
8-K
Departure of Directors or Certain Officers
16 May 23
10-Q
2023 Q1
Quarterly report
15 May 23
8-K
Amendments to Articles of Incorporation or Bylaws
11 May 23
8-K
First Quarter total product revenue of $2.3 million, an increase of 26% year-over-year
11 May 23
8-K
Submission of Matters to a Vote of Security Holders
10 May 23
8-K
Preliminary first quarter 2023 volume was 6,259 tests, an increase of 29% compared to last year, the highest volume quarter in the company’s history
28 Apr 23
ARS
2022 FY
Annual report to shareholders
4 Apr 23
DEFA14A
Additional proxy soliciting materials
3 Apr 23
DEF 14A
Definitive proxy
30 Mar 23
10-K
2022 FY
Annual report
30 Mar 23
Transcripts
AWH
Earnings call transcript
2023 Q1
11 May 23
AWH
Earnings call transcript
2022 Q4
22 Mar 23
AWH
Earnings call transcript
2022 Q3
10 Nov 22
AWH
Earnings call transcript
2022 Q2
10 Aug 22
AWH
Earnings call transcript
2022 Q1
11 May 22
AWH
Earnings call transcript
2021 Q4
23 Mar 22
AWH
Earnings call transcript
2021 Q3
10 Nov 21
AWH
Earnings call transcript
2021 Q2
13 Aug 21
AWH
Earnings call transcript
2021 Q1
14 May 21
AWH
Earnings call transcript
2020 Q4
26 Mar 21
Latest ownership filings
3
Ellen O'Connor Vos
18 May 23
3
Jannie Prestridge Herchuk
18 May 23
3
Stefanie L. Cavanaugh
18 May 23
4/A
Ryan Thinh Phan
21 Feb 23
SC 13G/A
SEAMARK CAPITAL LP
15 Feb 23
4
Robert D Auerbach
13 Feb 23
4
Veronica GH Jordan
13 Feb 23
4
Ruby Sharma
13 Feb 23
4
Celeste Rachelle Fralick
13 Feb 23
4
Nicole Sandford
13 Feb 23
Financial summary
| Quarter (USD) | Mar 23 | Dec 22 | Sep 22 | Jun 22 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Annual (USD) | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
|---|---|---|---|---|---|---|
| Cash on hand (at last report) | 7.79 mm | 7.79 mm | 7.79 mm | 7.79 mm | 7.79 mm | 7.79 mm |
| Cash burn (monthly) | 1.92 mm | 1.61 mm | 1.92 mm | 2.44 mm | 1.90 mm | 2.31 mm |
| Cash used (since last report) | 3.96 mm | 3.31 mm | 3.96 mm | 5.02 mm | 3.92 mm | 4.75 mm |
| Cash remaining | 3.83 mm | 4.47 mm | 3.83 mm | 2.76 mm | 3.87 mm | 3.03 mm |
| Runway (months of cash) | 2.0 | 2.8 | 2.0 | 1.1 | 2.0 | 1.3 |
Institutional ownership, Q4 2022
| 13F holders | Current |
|---|---|
| Total holders | 52 |
| Opened positions | 7 |
| Closed positions | 16 |
| Increased positions | 7 |
| Reduced positions | 16 |
| 13F shares | Current |
|---|---|
| Total value | 2.71 bn |
| Total shares | 67.67 mm |
| Total puts | 0.00 |
| Total calls | 100.00 |
| Total put/call ratio | – |
| Largest owners | Shares | Value |
|---|---|---|
| Schuler Jack W | 25.53 mm | $12.80 mm |
| Schuler Tino Hans | 8.57 mm | $31.80 mm |
| Schuler Henri George | 6.75 mm | $58.92 mm |
| Sharman Tanya Schuler | 5.94 mm | $12.19 mm |
| Seamark Capital | 5.67 mm | $0.00 |
| Larry N Feinberg | 5.55 mm | $13.48 mm |
| Vanguard | 2.72 mm | $906.17 mm |
| BLK Blackrock | 992.66 k | $330.16 mm |
| Oracle Investment Management | 728.10 k | $242.17 mm |
| National Asset Management | 663.07 k | $220.54 mm |
Recent insider trades
| Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 9 Feb 23 | Nicole Sandford | EMPLOYEE STOCK OPTION COMMON STOCK | Grant | Acquire A | No | No | 0.57 | 250,000 | 142.50 k | 250,000 |
| 9 Feb 23 | Nicole Sandford | EMPLOYEE STOCK OPTION COMMON STOCK | Grant | Acquire A | No | No | 0.57 | 500,000 | 285.00 k | 500,000 |
| 9 Feb 23 | Celeste Rachelle Fralick | COMMON STOCK | Grant | Acquire A | No | No | 0 | 66,254 | 0.00 | 169,199 |
News
Stocks That Hit 52-Week Lows On Thursday
1 Jun 23
Aspira Women's Health Announces The Publication Of Three Abstracts By The American Society Of Clinical Oncology Supporting The Clinical Utility Of OvaSuite Ovarian Cancer Risk Assessment Tests
31 May 23
Cantor Fitzgerald Maintains Neutral on Aspira Womens Health, Raises Price Target to $4.5
17 May 23
Aspira Women's Health Names Torsten Hombeck As Chief Financial Officer Replacing Interim CFO Marlene McLennan, Effective June 15, 2023
16 May 23
Stocks That Hit 52-Week Lows On Friday
12 May 23
Press releases
Aspira Women's Health to Participate at William Blair's 43rd Annual Growth Stock Conference
30 May 23
New to The Street Announces the Televised Lineups for Shows 471, 472, and 473; Airings on Three Networks Will Begin on Saturday, May 27, 2023, at 3:30 PM ET
26 May 23
New to The Street Announces its Televised Corporate Interviews Airing on Newsmax and The FOX Business Network, Episodes 469 and 470; Broadcastings Begin Saturday, May 20, 2023, at 3:30 PM ET
19 May 23
Aspira Women's Health to Present at the 2023 American College of Obstetricians and Gynecologists Annual Clinical & Scientific Conference
19 May 23
Aspira Women's Health Names Torsten Hombeck as Chief Financial Officer
16 May 23